4//SEC Filing
Andreatta Robert E 4
Accession 0001404219-09-000037
CIK 0000318771other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 2:56 PM ET
Size
22.3 KB
Accession
0001404219-09-000037
Insider Transaction Report
Form 4
Andreatta Robert E
CONTROLLER & CAO
Transactions
- Disposition to Issuer
Common Stock
2009-03-26$95.00/sh−1,263$119,985→ 0 total(indirect: By Trust) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−29,000→ 0 totalExercise: $79.55From: 2008-09-20Exp: 2017-09-20→ Common Stock (29,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−30,000→ 0 totalExercise: $85.83From: 2005-09-23Exp: 2015-09-23→ Common Stock (30,000 underlying) - Disposition to Issuer
Common Stock
2009-03-26$95.00/sh−834$79,230→ 0 total - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−6,500→ 0 totalExercise: $37.16From: 2003-06-20Exp: 2013-06-20→ Common Stock (6,500 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−4,500→ 0 totalExercise: $42.05From: 2003-09-11Exp: 2013-09-11→ Common Stock (4,500 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−15,700→ 0 totalExercise: $53.23From: 2004-09-23Exp: 2014-09-23→ Common Stock (15,700 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−20,000→ 0 totalExercise: $79.10From: 2006-06-16Exp: 2016-06-16→ Common Stock (20,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−14,000→ 0 totalExercise: $79.17From: 2007-09-20Exp: 2016-09-20→ Common Stock (14,000 underlying)
Footnotes (5)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger between the issuer, Roche Holdings Inc. and Roche Investments USA dated March 12, 2009.
- [F2]Shares are held in reporting person's revocable family trust.
- [F3]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.
- [F4]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.
- [F5]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.
Documents
Issuer
GENENTECH INC
CIK 0000318771
Entity typeother
Related Parties
1- filerCIK 0001396785
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 2:56 PM ET
- Size
- 22.3 KB